Follow Gene Ross at twitter@GeneRoss3; Follow AdultFYI at twitter@Adultfyi1

When is this industry going to stop with the nonsense that Diane Duke is some kind of guru of testing.

But don’t listen to me yap. Kora Peters writes on her blog www.korapetersblog.com –

“In the adult industry as of current, they are using either the HIV-1 NAT or the HIV-1RNA ‘tests’ on performers but after doing my homework I found that these rapid tests are only supposed to be used for screening plasma from blood donors but are NOT designed for diagnosis!

From PlOGS blogs: In resource-limited settings, HIV diagnosis is done with rapid diagnosis tests (RDT) using two or three different RDTs in either a serial or parallel algorithm (according to national guidelines).

Rapid tests allow scale up and decentralization of treatment, both of which are essential to saving lives. Yet RDTS are screening tests – they were not designed for definitive diagnosis [1]. They work well for screening blood transfusions and identifying people who need further tests, but are known to yield false positive results due to serological cross-reactivity (or to inadequate quality control and human error (e.g. mislabeling of specimens). Full article here false positives:

http://blogs.plos.org/speakingofmedicine/2012/01/03/false-positive-hiv-tests-the-problem-no-one-wants-to-talk-about-and-how-to-solve-it/

From Private MD Labs: This test is used for quantification of HIV-1 RNA in plasma of HIV-1 infected individuals. HIV-1 RNA results can be used to assess prognosis of disease progression and to monitor the efficacy of antiretroviral therapy by measuring changes in HIV-1 RNA levels during the course of therapy. The HIV-1 RNA (bDNA) assay is not intended for use as a screening test for HIV or as a diagnostic test to confirm the presence of HIV infection. The assay has been validated only for group M HIV-1 subtypes A-G. Here is the link: Private MD Labs

www.privatemdlabs.com/lp/HIV-1_RNA.php